320 related articles for article (PubMed ID: 25586024)
41. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S
J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830
[TBL] [Abstract][Full Text] [Related]
42. Phenotypic and genotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) from different sources in China.
Chao G; Zhang X; Zhang X; Huang Y; Xu L; Zhou L; Yang W; Jiang Y; Xue F; Wu Y
Foodborne Pathog Dis; 2013 Mar; 10(3):214-21. PubMed ID: 23405883
[TBL] [Abstract][Full Text] [Related]
43. In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains.
Diederen BM; van Duijn I; Willemse P; Kluytmans JA
Antimicrob Agents Chemother; 2006 Sep; 50(9):3189-91. PubMed ID: 16940127
[TBL] [Abstract][Full Text] [Related]
44. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
[TBL] [Abstract][Full Text] [Related]
45. Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents.
Lohan S; Cameotra SS; Bisht GS
Chem Biol Drug Des; 2013 Nov; 82(5):557-66. PubMed ID: 23819506
[TBL] [Abstract][Full Text] [Related]
46. Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Sader HS; Fritsche TR; Jones RN
Antimicrob Agents Chemother; 2008 Mar; 52(3):1153-5. PubMed ID: 18180353
[TBL] [Abstract][Full Text] [Related]
47. Linear Analogues of the Lipopeptide Battacin With Potent In Vitro Activity Against S. aureus.
Glossop HD; Pearl E; De Zoysa GH; Sarojini V
Adv Protein Chem Struct Biol; 2018; 112():385-394. PubMed ID: 29680242
[TBL] [Abstract][Full Text] [Related]
48. Potentiation of the activity of β-lactam antibiotics by farnesol and its derivatives.
Kim C; Hesek D; Lee M; Mobashery S
Bioorg Med Chem Lett; 2018 Feb; 28(4):642-645. PubMed ID: 29402738
[TBL] [Abstract][Full Text] [Related]
49. Alternative activity of beta-lactam antibiotics against methicillin- and cephem-resistant Staphylococcus aureus in the presence of respiratory tract mucus.
Igarashi K; Matsuyama T
J Infect Dis; 1990 Feb; 161(2):250-4. PubMed ID: 2299206
[TBL] [Abstract][Full Text] [Related]
50. Antagonism of chemical genetic interaction networks resensitize MRSA to β-lactam antibiotics.
Lee SH; Jarantow LW; Wang H; Sillaots S; Cheng H; Meredith TC; Thompson J; Roemer T
Chem Biol; 2011 Nov; 18(11):1379-89. PubMed ID: 22118672
[TBL] [Abstract][Full Text] [Related]
51. Synergistic effects between aminoethyl-chitosans and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
Lee DS; Kim YM; Lee MS; Ahn CB; Jung WK; Je JY
Bioorg Med Chem Lett; 2010 Feb; 20(3):975-8. PubMed ID: 20036533
[TBL] [Abstract][Full Text] [Related]
52. [Mini review: a factor enhanced the antibacterial effect of beta-lactams on methicillin-resistant Staphylococcus aureus].
Tajima Y
Rinsho Byori; 1996 Nov; 44(11):1093-9. PubMed ID: 8953942
[TBL] [Abstract][Full Text] [Related]
53. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
54. [Undecatungstophosphate sensitized strains of methicillin-resistant Staphylococcus aureus to beta-lactams].
Tajima Y
Rinsho Byori; 2002 Feb; 50(2):173-85. PubMed ID: 11925856
[TBL] [Abstract][Full Text] [Related]
55. Comparison of in vitro synergy of various β-lactams with vancomycin against methicillin-resistant Staphylococcus aureus.
Liao CH; Chen SY; Huang YT; Tsai HY; Hsueh PR
J Infect; 2017 Mar; 74(3):324-325. PubMed ID: 28065807
[No Abstract] [Full Text] [Related]
56. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.
Coombs GW; Daley DA; Thin Lee Y; Pearson JC; Robinson JO; Nimmo GR; Collignon P; Howden BP; Bell JM; Turnidge JD;
Commun Dis Intell Q Rep; 2016 Jun; 40(2):E244-54. PubMed ID: 27522136
[TBL] [Abstract][Full Text] [Related]
57. ILSMRs (intensifier of beta-lactam-susceptibility in methicillin-resistant Staphylococcus aureus) from Tara [Caesalpinia spinosa (Molina) Kuntze].
Kondo K; Takaishi Y; Shibata H; Higuti T
Phytomedicine; 2006 Feb; 13(3):209-12. PubMed ID: 16428032
[TBL] [Abstract][Full Text] [Related]
58. In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
Betts JW; Sharili AS; Phee LM; Wareham DW
J Nat Prod; 2015 Aug; 78(8):2145-8. PubMed ID: 26267658
[TBL] [Abstract][Full Text] [Related]
59. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro.
Goh S; Loeffler A; Lloyd DH; Nair SP; Good L
BMC Microbiol; 2015 Nov; 15():262. PubMed ID: 26560174
[TBL] [Abstract][Full Text] [Related]
60. Human Microbiome Inspired Antibiotics with Improved β-Lactam Synergy against MDR Staphylococcus aureus.
Chu J; Vila-Farres X; Inoyama D; Gallardo-Macias R; Jaskowski M; Satish S; Freundlich JS; Brady SF
ACS Infect Dis; 2018 Jan; 4(1):33-38. PubMed ID: 28845973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
